Join Growin Stock Community!

Aurora cannabis inc.ACB.US Overview

US StockHealthcare
(No presentation for ACB)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ACB AI Insights

ACB Overall Performance

ACB AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ACB Recent Performance

-2.21%

Aurora cannabis inc.

0.05%

Avg of Sector

-0.31%

S&P500

ACB PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ACB Key Information

ACB Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

ACB Profile

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Price of ACB

ACB FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ACB Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.99
PE Ratio (TTM)
-
Forward PE
7.72
PS Ratio (TTM)
0.58
PB Ratio
0.56
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.51%
Net Margin
-30.22%
Revenue Growth (YoY)
9.43%
Profit Growth (YoY)
-47.38%
3-Year Revenue Growth
13.73%
3-Year Profit Growth
35.71%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.99
PE Ratio (TTM)
-
Forward PE
7.72
PS Ratio (TTM)
0.58
PB Ratio
0.56
Price-to-FCF
-
Gross Margin
34.51%
Net Margin
-30.22%
Revenue Growth (YoY)
9.43%
Profit Growth (YoY)
-47.38%
3-Year Revenue Growth
13.73%
3-Year Profit Growth
35.71%

  • When is ACB's latest earnings report released?

    The most recent financial report for Aurora cannabis inc. (ACB) covers the period of 2026Q3 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ACB's short-term business performance and financial health. For the latest updates on ACB's earnings releases, visit this page regularly.

  • What is the operating profit of ACB?

    According to the latest financial report, Aurora cannabis inc. (ACB) reported an Operating Profit of 2.18M with an Operating Margin of 2.32% this period, representing a decline of 94.07% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ACB's revenue growth?

    In the latest financial report, Aurora cannabis inc. (ACB) announced revenue of 94.19M, with a Year-Over-Year growth rate of 6.79%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ACB have?

    As of the end of the reporting period, Aurora cannabis inc. (ACB) had total debt of 101M, with a debt ratio of 0.13. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ACB have?

    At the end of the period, Aurora cannabis inc. (ACB) held Total Cash and Cash Equivalents of 102.35M, accounting for 0.13 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ACB go with three margins increasing?

    In the latest report, Aurora cannabis inc. (ACB) did not achieve the “three margins increasing” benchmark, with a gross margin of 49.5%%, operating margin of 2.32%%, and net margin of -9.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ACB's profit trajectory and future growth potential.

  • Is ACB's EPS continuing to grow?

    According to the past four quarterly reports, Aurora cannabis inc. (ACB)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.03. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ACB?

    Aurora cannabis inc. (ACB)'s Free Cash Flow (FCF) for the period is 11.6M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 51.63% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ACB?

    The latest valuation data shows Aurora cannabis inc. (ACB) has a Price-To-Earnings (PE) ratio of -2.6 and a Price/Earnings-To-Growth (PEG) ratio of -0.44. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.